COMMUNICATIONS
Keywords: asymmetric catalysis ´ epoxidations ´ heteroge-
neous catalysis ´ surface chemistry ´ tantalum
Total Synthesis of ()-Halichlorine:
An Inhibitor of VCAM-1 Expression**
Dirk Trauner, Jacob B. Schwarz, and
Samuel J. Danishefsky*
[1] B. E. Rossiter in Asymmetric Synthesis, Vol. 5 (Ed.: J. D. Morrison),
Academic Press, New York, 1985, p. 193.
[2] M. Bulliard, W. Shum, Proceedings of the Chiral ꢀ95 USA Symposium,
1995, p. 5.
[3] T. Katsuki, K. B. Sharpless, J. Am. Chem. Soc. 1980, 102, 5974.
[4] J. N. Armor, Appl. Catal. 1991, 78, 141.
[5] M. G. Finn, K. B. Sharpless J. Am. Chem. Soc. 1991, 113, 113.
[6] R. M. Hanson, K. B. Sharpless, J. Org. Chem. 1986, 51, 1922.
[7] Y. Gao, R. M. Hanson, J. M. Klunder, S. Y. Ko, H. Masamune, K. B.
Sharpless, J. Am. Chem. Soc. 1987, 109, 5765.
[8] R. A. Johnson, K. B. Sharpless in Comprehensive Organic Synthesis,
Vol. 7 (Eds.: B. M. Trost, I. Fleming), Pergamon, Oxford, 1991,
p. 389.
[9] A. Baiker, H. U. Blaser in Handbook of Heterogeneous Catalysis, Vol.
5 (Eds.: G. Ertl, H. Knözinger, J. Weitkamp), VCH, Weinheim, 1997,
p. 2432.
[10] G. J. Hutchings, D. F. Lee, A. R. Minihan, Catal. Lett. 1995, 33,
369.
[11] C. Cativiela, J. M. Fraile, J. I. Garcia, J. A. Mayoral, J. Mol. Catal.
1996, 112, 259.
[12] W. Adam, A. Corma, A. Martinez, C. M. Mitchell, T. I. Reddy, M.
Renz, A. K. Smertz, J. Mol. Catal. 1997, 117, 357.
[13] B. M. Choudary, V. L. K. Valli, A. D. Prasad, J. Chem. Soc. Chem.
Commun. 1990, 1186.
Vascular cell adhesion molecule-1 (VCAM-1), a member of
the immunoglobulin superfamily, monitors and regulates
leukocyte recruitment into inflamed tissue.[1] Since leukocyte
infiltration is involved in various allergic inflammatory
disorders as well as pathogenic processes such as asthma
and arteriosclerosis VCAM-1 has emerged as a potential
target for drug discovery. In principle, blockade or inhibition
of VCAM-1 could have consequences in regulating leukocyte
trafficking. Given such considerations an agent that specifi-
cally inhibits induced VCAM-1 expression could be of
particular interest. While screening for active compounds
from marine organisms Uemura and colleagues isolated a
substance from the marine sponge Halichondria okadai Ka-
dota, which they named halichlorine, and identified its
structure as 1.[2] A related structure, pinnaic acid (2), had
been isolated from an Okinawan bivalve Pinna muricata.[3]
H
[14] V. Dufaud, G. P. Niccolai, J. Thivolle-Cazat, J. M. Basset, J. Am. Chem.
Soc. 1995, 117, 15.
HOOC
5
HN
O
N
[15] This already known surface reaction[14] leads to the liberation of
neopentane (ca. 1.5 mol per mol of grafted Ta) with the formation of a
mixture of two well-defined surface species, 2a and 2b.
[16] Step 2: 2.5 mol of neopentane evolved per mol of surface
tantalum.
9
1
O
13
Me
Me
Cl
14
14
Cl
17
HO
OH
17
[17] [Ta]#1: 4.92 wt% Ta, C/Ta 8.9; [Ta]#2: 5.40 wt% Ta, C/Ta 7.2;
[Ta]#3: 5.63 wt% Ta, C/Ta 7.1. For a mixture of 3a (50%) and 3b
(50%) a theoretical value of C/Ta 7 should be observed; this is the
case for [Ta]#2 and [Ta]#3. For [Ta]#1 the higher value may be
explained by the presence of SiOEt species.
[18] R. A. Sheldon, M. Wallau, I. W. C. E. Arends, U. Schuchardt Acc.
Chem. Res. 1998, 31, 485.
[19] L. G. Hubert-Pfalzgraf, J. Guion, J. G. Riess, Bull. Soc. Chim. Fr. 1971,
11, 3855.
OH
2
1
Aside from several provocative features of halichlorine,
which might pose stimulating opportunities to the organic
chemist, this compound commands particular attention be-
cause it selectively inhibits the induced expression of VCAM-
1
1 with an IC50 of 7 mgmL . Interestingly, pinnaic acid was
[20] R. R. Schrock, J. D. Fellmann, J. Am. Chem. Soc. 1978, 100, 3359.
obtained from a screen designed to identify specific inhibitors
of cytosolic phospholipase A2 (cPLA2).
Among the challenges posed by halichlorine is that of its
total synthesis.[4] Aside from providing the setting for
addressing several interesting chemical issues, its total syn-
thesis holds the prospect of providing probe structures to
document structure ± activity relationships. Elsewhere we
[*] Prof. S. J. Danishefsky,[] Dr. D. Trauner, Dr. J. B. Schwarz
Laboratory for Bioorganic Chemistry
Sloan-Kettering Institute for Cancer Research
1275 York Avenue, New York, NY 10021 (USA)
Fax: (1)212-772-8691
Further address:
[ ] Department of Chemistry
Columbia University
Havemeyer Hall, New York, NY 10027 (USA)
[**] This work was supported by the National Institutes of Health (Grant
numbers: CA-28824 (S.J.D), CA-08748 (Sloan Kettering Institute
Core Grant), and NIH-F3218804 (J.B.S.)). D.T. gratefully acknowl-
edges the Schering Research Foundation, Berlin, for a postdoctoral
fellowship. We thank George Suckenick of the NMR Core Facility for
mass spectral analyses.
3542
ꢀ WILEY-VCH Verlag GmbH, D-69451 Weinheim, 1999
1433-7851/99/3823-3542 $ 17.50+.50/0
Angew. Chem. Int. Ed. 1999, 38, No. 23